Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
World Stock Indices Examples presents representative benchmarks from major economies to illustrate global market movements.
22,492 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Oil prices surge on supply concerns, pushing the S&P 500 lower as investors rotate into energy names. This stock mark...
Fidelity’s Active Large Growth ETF threads a narrow but meaningful edge over passive peers as AI-enabled demand fuels...
Disney, McDonald’s, Microsoft, and Procter & Gamble now appear oversold despite solid earnings and durable consumer s...
UBS analysts warn that aging housing stock could spark a repair-driven upcycle for major home-improvement retailers. ...
Figma trades higher ahead of tonight’s Q1 print, as analysts eye revenue growth and AI momentum. Live coverage tracks...
When markets wobble, fear can block smart moves. This guide walks you through a calm, practical approach to a market ...
As volatility lingers in 2026, Realty Income (O) stands out with a steady monthly payout and a long history of divide...
One staffing stock plunged 56% in the last year, but a large new stake worth almost $10 million could signal a forthc...
SpaceX used its soaring stock to fund a $60 billion Cursor acquisition in stock, turning a fresh IPO into a powerful ...
A high-quality stock has endured a 19% drop over seven months. This article breaks down how to tell whether the decli...
When MoonLake Immunotherapeutics announced a larger-than-expected secondary offering, the stock wilted. This guide br...